Quality Indicators for the Diagnosis and Management of Primary Hyperparathyroidism.

ABSTRACT:

Importance

Primary hyperparathyroidism (pHPT) is a common endocrine disorder with many diagnostic and treatment challenges. Despite high-quality guidelines, care is variable, and there is low adherence to evidence-based treatment pathways.

Objective

To develop quality indicators (QIs) to evaluate the diagnosis and treatment of pHPT that could measure, improve, and optimize quality of care and outcomes for patients with this disease.

Design, setting, and participants

This quality improvement study used a guideline-based approach to develop QIs that were ranked by a Canadian 9-member expert panel of 3 endocrinologists, 3 otolaryngologists, and 3 endocrine surgeons. Data were analyzed between September 2020 and May 2021.

Main outcomes and measures

Candidate indica

SUBMITTER: Noltes ME 

PROVIDER: S-EPMC8739767 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature